Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Nebraska extends Matt Rhule's contract through 2032, resetting his buyout and tying his pay to playoff appearances.
Goldman Sachs CEO warns of a looming 'reckoning' for the US economy if government debt continues to rise without a corresponding increase in economic growth.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Nebraska extends Matt Rhule's contract through 2032, resetting his buyout and tying his pay to playoff appearances.
Goldman Sachs CEO warns of a looming 'reckoning' for the US economy if government debt continues to rise without a corresponding increase in economic growth.